BSECompany Update11 Aug 2026 · 11 Aug 2026, 05:00 pm
Statement of Deviation and Variation for the Quarter Ended 30th June, 2026
JHS Svendgaard Laboratories Ltd · 532771
✦ AI Summary
JHS Svendgaard Laboratories Ltd has filed a statement of deviation and variation for the quarter ended June 30, 2026, under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, regarding the utilization of funds raised through a preferential issue.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
JHS Svendgaard Laboratories Ltd - 532771 - Statement Of Deviation & Variation
Attachments (1)
📄pdf
Download →
bc9cea92-e09e-42fd-8319-2bcdeb99b6f1.pdf
View document text
CIN:L74110HP2004PLC027558
To August 11, 2026
The Listing Department The Listing Department
Bombay Stock Exchange Limited National Stock Exchange of India Limited
Department of Corporate Services Exchange Plaza, C-1, Block-G
Phiroze Jeejeebhoy Towers, Bandra Kurla Complex
Dalal Street, Mumbai – 400001 Mumbai – 400051
Scrip Code: 532771 Trading Symbol: JHS
Subject: Statement of Deviation or Variation under Regulation 32 of SEBI (Listing Obligations and
Disclosure Requirements) Regulation, 2015 for the Quarter ended June 30, 2026.
Dear Sir,
Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015, please find enclosed herewith the Statement of Deviation or Variation for the quarter ended
June 30, 2026, in respect of the utilization of funds raised through Preferential Issue by the Company,
as approved by the Board of Directors at its meeting held on August 11, 2026.
This information is available on the website of the Company viz., www.svendgaard.com.
Kindly take the same on records.
Thanking You,
For JHS Svendgaard Laboratories Limited
Komal Jha
Company Secretary & Compliance officer
Encl: A/a
CIN:L74110HP2004PLC027558
ANNEXURE-A
Statement of Deviation / Variation in utilization of Funds Raised
Particulars Details
Name of listed entity JHS Svendgaard Laboratories Limited
Mode of Fund Raising Preferential Issue
Date of Raising Funds
04th June 2024
Amount Raised Rs. 29.99 crores
Report filed for Quarter ended June 30, 2026
Monitoring Agency N.A.
Monitoring Agency Name, if
N.A.
applicable
Is there a Deviation / Variation in use
of funds raised
If yes, whether the same is pursuant to
change in terms of a contract or
N.A.
objects, which was approved by the
shareholders
If Yes, Date of shareholder Approval 04th July, 2024
Explanation for the Deviation /
Variation
Comments of the Audit Committee
after review
Comments of the auditors, if any NIL
CIN:L74110HP2004PLC027558
Amount of
Modified Deviation/Variation
Original Funds
Sr. No. Original Object Modified Object, if any allocation, for the quarter
Allocation Utilised
if any according to
applicable object
1 For Setting Up new Fund the capital 2249.99 764.99 764.46 0.00
Project in Jammu & expenditure for
Kashmir under acquiring equipment
Industrial for
Development manufacturing facility.
Scheme (IDS) 2021-
2030, J&K
2 For General N.A. 750.00 0.00 749.50 0.00
Corporate Purpose
3 NA Infusion of funds in 0.00 1110.01 962.50 0.00
Group entity i.e. JHS
Svendgaard Retail
Ventures Ltd., for
funding the expansion
plan through
strategic fund infusion